STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $133,180 | -6.2% | 14,429 | +30.6% | 0.00% | -50.0% |
| Q3 2022 | $142,000 | -89.1% | 11,047 | -82.2% | 0.00% | -75.0% |
| Q1 2022 | $1,306,000 | +17.2% | 62,065 | +33.6% | 0.01% | +33.3% |
| Q4 2021 | $1,114,000 | +34.7% | 46,441 | +42.8% | 0.01% | 0.0% |
| Q3 2021 | $827,000 | -25.1% | 32,515 | -0.8% | 0.01% | -14.3% |
| Q2 2021 | $1,104,000 | -18.3% | 32,793 | -5.8% | 0.01% | -22.2% |
| Q1 2021 | $1,352,000 | – | 34,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |